Synexis Dry Hydrogen Peroxide (DHP™) Technology Significantly Reduces Microbial Contamination On Privacy Curtains In A Tertiary Care Hospital Setting
LENEXA, Kan., June 15, 2021 / PRNewswire / – Synexis® LLC, the sole developer of patented dry hydrogen peroxide (DHP™) Technology, announced a new study publication examining the use of DHP technology in tertiary care hospitals. The study published online in American Journal for Infection Control, evaluated the effectiveness of continuously operated DHP™ Technology to reduce microbial contamination of privacy curtains during use and between changes in five different units1 inside the hospital. The results showed a significant reduction in microbial contaminants after the first day, with the reduction lasting for 28 days.
“Privacy curtains, which are often left unchanged after a patient is discharged, can become contaminated and harbor pathogens that include multidrug-resistant bacteria,” said Jennifer Sanguinet, DrPh, FAPIC, CIC, MBA-HCM, BSIS, study director. “These results show that continued use of DHP™ Technology can provide an effective and automated approach to reducing the potential risk of infection from contamination between curtain changes. “
In this study, three consecutive days before the installation of Synexis DHP. Samples of 45 privacy curtains measured on the basis of surface microbes™ Units. The germ counts of the 45 curtain samples were averaged and represented the baseline numbers against which the post-DHPTM Results of the implementation samples were compared. On study days 1, 7 and 28, respectively, the results showed a rapid and sustained reduction in the number of germs by 99.47%, 98.55% and 96.59% (P <0.001 for all results compared to the initial values).2
“Without interrupting clinical care or having to remove patients from their rooms, this study shows that DHP™ Technology is particularly effective in reducing contamination of privacy curtains that are often not switched between patients, “said Eric Schlote, CEO of Synexis. “This paper is the fifth peer-reviewed study on Synexis DHP. has been published™. These results complement the growing body of peer-reviewed evidence supporting the effectiveness of DHP. occupy™ to reduce the microbial load in several settings. ”
Synexis® LLC was founded in 2008 and is a leader in microbial reduction and the only developer of a patented technology, DHP. generated and continuously dispersed™ (Dry hydrogen peroxide) to reduce the presence of microbes in inhabited rooms 24/7 without the need for residents to leave the room.3.4
Synexis develops state-of-the-art bio-defense systems that make air and surfaces cleaner. Synexis BioDefense systems are regulated by the US Environmental Protection Agency (EPA) and state governments as antimicrobial devices. Accordingly, Synexis systems are manufactured in an EPA registered facility and are packaged and labeled in accordance with EPA regulations which appear at 40 CFR 152,500. The Synexis system is certified by Underwriter Laboratories (UL) to not produce ozone and operates continuously without interrupting normal operations or workflow.5 Synexis currently holds 16 patents, 16 of which are pending.6th In addition, Synexis DHP technology is supported by data from five peer-reviewed studies.7,8,9,10,11
For more information, visit Synexis.com.
Disclaimer: Synexis does not claim that the study described reflects the product’s ability to prevent the spread of the SARS-CoV-2 virus. The FDA has not approved DHP™ to curb the spread of the virus.
1 Units included the pediatric emergency room, pediatric intensive care unit, adult oncology service, adult cardiovascular trauma intensive care unit, and adult traumatological intensive care unit.
2 Sanguinet, J., & Lee, C. An effective and automated approach to reducing the risk of infection from contaminated privacy curtains. AJIC (2021). https://www.ajicjournal.org/article/S0196-6553(21)00402-8/fulltext.
3 Synexis https://synexis.com/patents/. Accessed April 12, 2021.
4th UL certification numbers: Blade UL E482400, Sentry UL E495096, and Sphere UL 2998.
5 UL certification numbers: Blade UL E482400, Sentry UL E495096, and Sphere UL 2998.
6th Synexis https://synexis.com/patents/. Accessed April 12, 2021.
7th Infection specialists and pharmacists are jointly responsible for ensuring patient safety; Pharmacy times. Released 23rd November 2020.
8th Melgar, M., et al. Effect of dry hydrogen peroxide on reducing the risk of microbial contamination in the environment in a pediatric oncology intensive care unit. AJIC (2020). https://doi.org/10.1016/j.ajic.2020.08.026.
9 Melo, EF & McElreath, JS & Wilson, JL & Lara, Leonardo & Cox, NA & Jordan, Brian. (2020). Effects of a dry hydrogen peroxide disinfection system in an egg cooler on hatchability and chick quality. poultry Science. vol. 99 Nov 2020. https://doi.org/10.1016/j.psj.2020.05.050.
10 Sanguinet, J., & Lee, C. An effective and automated approach to reducing the risk of infection from contaminated privacy curtains. AJIC (2021). https://www.ajicjournal.org/article/S0196-6553(21)00402-8/fulltext.
11 Herman CK, Hess J, Cerra C. Diluted hydrogen peroxide technology to reduce microbial colonization in the hospital environment. AJIC. 2015; 43 (6S): S25-S26. doi: 10.1016 / j.ajic.2015.04.064.
SOURCE Synexis LLC